Jacqueline Earabino, RN BSN

Jacqueline Earabino, RN BSN has had extensive work experience in the field of clinical operations. Jacqueline is currently serving as the Head of Clinical Operations at Lytix Biopharma since January 2022. Prior to their current position, they worked as the Clinical Operations Program Lead for COVID-19 and RSV adult vaccine programs at Meissa Vaccines from August 2020 to January 2022.

Before joining Meissa Vaccines, Jacqueline held the role of Director of Clinical Operations and COVID Program Lead at Reven Pharmaceuticals from November 2019 to August 2020. Jacqueline also served as the Director of Clinical Operations for the Oncology Breast Cancer Program at Odonate Therapeutics from June 2017 to September 2019.

From August 2009 to June 2017, Jacqueline worked at Barnett International, where they served as a Writer & Trainer, specializing in CRA/GCP and Oncology Subject Matter Expert. Prior to that, they gained experience as a Sr. Clinical Project Manager in Oncology at Avillion LLP from February 2014 to October 2015.

Earlier in their career, Jacqueline worked as a Sr. Global Clinical Trial Manager in Oncology at Novella Clinical from an unspecified date in 2009 to March 2014. Jacqueline also served as a Clinical Operations Lead at Strategic Solutions from October 2012 to February 2014.

Overall, Jacqueline Earabino's work experience demonstrates their expertise in clinical operations and their ability to successfully manage and lead various clinical programs and projects in the pharmaceutical and biotechnology industry.

Jacqueline Earabino, RN BSN pursued their education at The Johns Hopkins University from 1992 to 1994, where they earned a Bachelor of Science degree in Nursing. In addition, they attended New England College, obtaining a Bachelor of Science degree in Biology/Environmental Science.